"Immune System Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
| Descriptor ID |
D007154
|
| MeSH Number(s) |
C20
|
| Concept/Terms |
Immune System Diseases- Immune System Diseases
- Disease, Immune System
- Diseases, Immune System
- Immune System Disease
- Immunological Diseases
- Disease, Immunological
- Diseases, Immunological
- Immunological Disease
- Immune Disorders
- Disorder, Immune
- Disorders, Immune
- Immune Disorder
- Immunologic Diseases
- Disease, Immunologic
- Diseases, Immunologic
- Immunologic Disease
- Diseases of Immune System
- Immune Diseases
- Disease, Immune
- Diseases, Immune
- Immune Disease
|
Below are MeSH descriptors whose meaning is more general than "Immune System Diseases".
Below are MeSH descriptors whose meaning is more specific than "Immune System Diseases".
This graph shows the total number of publications written about "Immune System Diseases" by people in this website by year, and whether "Immune System Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immune System Diseases" by people in Profiles.
-
Discovery of new myositis genetic associations through leveraging other immune-mediated diseases. HGG Adv. 2024 Oct 10; 5(4):100336.
-
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev. 2024 03; 322(1):311-328.
-
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events. Front Immunol. 2023; 14:1322818.
-
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected Melanoma. JAMA Netw Open. 2023 08 01; 6(8):e2327145.
-
Burden of atopic disease in Black and Hispanic patients with alopecia areata: a case-control study in the All of Us research program. Int J Dermatol. 2023 07; 62(7):e393-e394.
-
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022 11 01; 132(21).
-
Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects. Cell Mol Immunol. 2023 01; 20(1):11-25.
-
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023 04; 151(4):1081-1095.
-
Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open. 2021 03; 6(1):62-72.
-
Artificial intelligence and the hunt for immunological disorders. Curr Opin Allergy Clin Immunol. 2020 12; 20(6):565-573.